Medication Management

Aurobindo gets FDA green light for generic Tobi

Aurobindo’s generic tobramycin inhalation solution is used to treat cystic fibrosis in adults and pediatric patients age 6 years old and older with Pseudomonas aeruginosa.
ViiV Healthcare obtains FDA OK for HIV drug regimen

ViiV Healthcare’s Cabenuva is the first Food and Drug Administration-approved injectable that is a complete regimen for HIV-infected adults administered once a month.
Strides Pharma obtains FDA clearance for generic Actigal

Ursodiol capsules had a market value of approximately $45 million, according to IQVIA November data.
Zydus Cadila obtains FDA OK for generic Cytomel

Zydus Cadila’s generic Cytomel will be available in dosage strengths of 5 mcg, 25 mcg, and 50 mcg.
Alembic gets FDA nod for generic ProAmatine

Midodrine hydrochloride tablets have a market value of roughly $60 million for the 12 months ended September 2020, according to IQVIA.
Camber intros generic Effexor

Camber's generic Effexor is available in dosage strengths of 37.5 mg, 75 mg, 150 mg and 225 mg.
Merck obtains FDA nod for Verquvo

Merck's Verquvo offers a new treatment option for appropriate patients with symptomatic chronic heart failure.
Sun Pharma intros 2 generics

Sun Pharma is launching docetaxel injection and relaunching its valacyclovir tablets.

Lupin gets FDA nod for generic Renvela